|
|
||||||||
The Journal of Immunology, Vol 154, Issue 9 4341-4350, Copyright © 1995 by American Association of Immunologists
ARTICLES |
K Itoh and S Hirohata
Second Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Recent studies have disclosed variable effects of IL-10 on viabilities of human B lineage cells. Thus, IL-10 has been shown to prevent apoptosis of germinal center B cells, whereas IL-10 has been found to induce apoptosis of B-chronic lymphocytic leukemia cells, suggesting the possibility that the effects of IL-10 might be different depending on the state of activation of B cells. The current studies therefore examined in detail the regulation of the survival of human peripheral blood B cells by IL-10 and its relevance to Ig production. Highly purified B cells from healthy adult individuals were cultured with Staphylococcus aureus (SA) Cowan I in the presence or absence of IL-10. When IL-10 was present during the initial activation of B cells with SA, IL-10 facilitated the apoptosis of SA-activated B cells, as determined by staining with propidium iodide, followed by analysis with flow cytometry, thus resulting in very modest IgM production. IL-2 prevented the IL-10-mediated progression of the apoptosis of SA- activated B cells during the initial activation, and thus restored the further differentiation of these B cells into Ig secreting cells. By contrast, IL-10 rather rescued SA-activated B cells from apoptosis and thus supported the differentiation of these B cells without any influences of IL-2, when it was added after 72 h of culture. Of note, cyclosporin A prevented the IL-10-mediated promotion of the apoptosis of SA-activated B cells, thus resulting in the marked enhancement of IgM production of B cells stimulated with SA + IL-10. Finally, the promotion or prevention of the IL-10-mediated apoptosis was correlated with the expression of Bcl-2 oncoprotein in SA-activated B cells. These results indicate that the effects of IL-10 are different depending on the state of activation of B cells after ligation of Ag receptors. Thus, the data have demonstrated that IL-10 during the initial activation delivers negative signals that promote the apoptosis of B cells, whereas IL-10 supports the differentiation of B cells in the complete absence of IL-2 during the subsequent responses following activation. These results therefore emphasize unique biphasic effects of IL-10 on human B cell responsiveness in determining the outcome of humoral immune responses.
This article has been cited by other articles:
![]() |
S. Kuchen, R. Robbins, G. P. Sims, C. Sheng, T. M. Phillips, P. E. Lipsky, and R. Ettinger Essential Role of IL-21 in B Cell Activation, Expansion, and Plasma Cell Generation during CD4+ T Cell-B Cell Collaboration J. Immunol., November 1, 2007; 179(9): 5886 - 5896. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Lee, K.-A Lee, and J. Chang Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation Int. Immunol., September 6, 2007; (2007) dxm072v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Touitou, C. Daussy, B. Bodaghi, S. Camelo, Y. de Kozak, P. Lehoang, M.-C. Naud, A. Varin, B. Thillaye-Goldenberg, H. Merle-Beral, et al. Impaired Th1/Tc1 Cytokine Production of Tumor-Infiltrating Lymphocytes in a Model of Primary Intraocular B-Cell Lymphoma Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3223 - 3229. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Szodoray, P. Alex, M. B. Frank, M. Turner, S. Turner, N. Knowlton, C. Cadwell, I. Dozmorov, Y. Tang, P. C. Wilson, et al. A genome-scale assessment of peripheral blood B-cell molecular homeostasis in patients with rheumatoid arthritis Rheumatology, December 1, 2006; 45(12): 1466 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Lopez, S. K. Adris, A. I. Bravo, Y. Chernajovsky, and O. L. Podhajcer IL-12 and IL-10 Expression Synergize to Induce the Immune-Mediated Eradication of Established Colon and Mammary Tumors and Lung Metastasis J. Immunol., November 1, 2005; 175(9): 5885 - 5894. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Kang and P. M. Allen Priming in the Presence of IL-10 Results in Direct Enhancement of CD8+ T Cell Primary Responses and Inhibition of Secondary Responses J. Immunol., May 1, 2005; 174(9): 5382 - 5389. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Halvorsen, T. Waehre, H. Scholz, O. P. Clausen, J. H. von der Thusen, F. Muller, H. Heimli, S. Tonstad, C. Hall, S. S. Froland, et al. Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms J. Lipid Res., February 1, 2005; 46(2): 211 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
M R A. Kashipaz, M L Huggins, P Lanyon, A Robins, R J Powell, and I Todd Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10 producing CD5+ B cells Lupus, May 1, 2003; 12(5): 356 - 363. [Abstract] [PDF] |
||||
![]() |
C. G. Lee, R. J. Homer, L. Cohn, H. Link, S. Jung, J. E. Craft, B. S. Graham, T. R. Johnson, and J. A. Elias Transgenic Overexpression of Interleukin (IL)-10 in the Lung Causes Mucus Metaplasia, Tissue Inflammation, and Airway Remodeling via IL-13-dependent and -independent Pathways J. Biol. Chem., September 13, 2002; 277(38): 35466 - 35474. [Abstract] [Full Text] [PDF] |
||||
![]() |
I Y Rosenblum and A D Dayan Carcinogenicity testing of IL-10: principles and practicalities Human and Experimental Toxicology, July 1, 2002; 21(7): 347 - 358. [Abstract] [PDF] |
||||
![]() |
S. Hirohata, T. Yanagida, T. Tomita, H. Yoshikawa, and T. Ochi Bone marrow CD34+ progenitor cells stimulated with stem cell factor and GM-CSF have the capacity to activate IgD- B cells through direct cellular interaction J. Leukoc. Biol., June 1, 2002; 71(6): 987 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. He, C. M. Weyand, J. J. Goronzy, W. Zhong, and J. M. Stuart Bi-directional modulation of T cell-dependent antibody production by prostaglandin E2 Int. Immunol., January 1, 2002; 14(1): 69 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Lopatin, X. Yao, R. K. Williams, J. J. H. Bleesing, J. K. Dale, D. Wong, J. Teruya-Feldstein, S. Fritz, M. R. Morrow, I. Fuss, et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression Blood, May 15, 2001; 97(10): 3161 - 3170. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Yeatman , II, S. M. Jacobs-Helber, P. Mirmonsef, S. R. Gillespie, L. A. Bouton, H. A. Collins, S. T. Sawyer, C. P. Shelburne, and J. J. Ryan Combined Stimulation with the T Helper Cell Type 2 Cytokines Interleukin (IL)-4 and IL-10 Induces Mouse Mast Cell Apoptosis J. Exp. Med., October 9, 2000; 192(8): 1093 - 1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bellone, A. Turletti, E. Artusio, K. Mareschi, A. Carbone, D. Tibaudi, A. Robecchi, G. Emanuelli, and U. Rodeck Tumor-Associated Transforming Growth Factor-{beta} and Interleukin-10 Contribute to a Systemic Th2 Immune Phenotype in Pancreatic Carcinoma Patients Am. J. Pathol., August 1, 1999; 155(2): 537 - 547. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Adib-Conquy, A.-F. Petit, C. Marie, C. Fitting, and J.-M. Cavaillon Paradoxical priming effects of IL-10 on cytokine production Int. Immunol., May 1, 1999; 11(5): 689 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Coccia and P. Brams High Titer, Prostate Specific Antigen-Specific Human IgG Production by hu-PBL-SCID Mice Immunized with Antigen-Mouse IgG2a Complex-Pulsed Autologous Dendritic Cells J. Immunol., November 15, 1998; 161(10): 5772 - 5780. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Raisanen-Sokolowski, T. Glysing-Jensen, and M. E. Russell Leukocyte-Suppressing Influences of Interleukin (IL)-10 in Cardiac Allografts : Insights from IL-10 Knockout Mice Am. J. Pathol., November 1, 1998; 153(5): 1491 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Eskdale, G. Gallagher, C. L. Verweij, V. Keijsers, R. G. J. Westendorp, and T. W. J. Huizinga Interleukin 10 secretion in relation to human IL-10 locus haplotypes PNAS, August 4, 1998; 95(16): 9465 - 9470. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Wagner, M. Hleb, N. Hanna, and S. Sharma A Pivotal Role of Cyclin D3 and Cyclin-Dependent Kinase Inhibitor p27 in the Regulation of IL-2-, IL-4-, or IL-10-Mediated Human B Cell Proliferation J. Immunol., August 1, 1998; 161(3): 1123 - 1131. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Trueblood, W. C. Brown, G. H. Palmer, W. C. Davis, D. M. Stone, and T. F. McElwain B-Lymphocyte Proliferation during Bovine Leukemia VirusInduced Persistent Lymphocytosis Is Enhanced by T-Lymphocyte-Derived Interleukin-2 J. Virol., April 1, 1998; 72(4): 3169 - 3177. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Agematsu, H. Nagumo, Y. Oguchi, T. Nakazawa, K. Fukushima, K. Yasui, S. Ito, T. Kobata, C. Morimoto, and A. Komiyama Generation of Plasma Cells From Peripheral Blood Memory B Cells: Synergistic Effect of Interleukin-10 and CD27/CD70 Interaction Blood, January 1, 1998; 91(1): 173 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. P. Veiby, O. J. Borge, A. Martensson, E. X. Beck, A. E. Schade, K. Grzegorzewski, S. D. Lyman, I.-L. Martensson, and S. E.W. Jacobsen Bidirectional Effect of Interleukin-10 on Early Murine B-Cell Development: Stimulation of flt3-Ligand Plus Interleukin-7-Dependent Generation of CD19- ProB Cells From Uncommitted Bone Marrow Progenitor Cells and Growth Inhibition of CD19+ ProB Cells Blood, December 1, 1997; 90(11): 4321 - 4331. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Kuo and J. Sklar Augmented Expression of a Human Gene for 8-oxoguanine DNA Glycosylase (MutM) in B Lymphocytes of the Dark Zone in Lymph Node Germinal Centers J. Exp. Med., November 3, 1997; 186(9): 1547 - 1556. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |